FDA Approved: FLUTICASONE FUROATE ELLIPTA — Supplemental Application (Prasco Laboratories)

View source ↗

Summary

FDA approved a supplemental application for Fluticasone Furoate Ellipta from Prasco Laboratories.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Fluticasone furoate Ellipta (Fluticasone furoate)

Snippet

SUPPL AP for FLUTICASONE FUROATE ELLIPTA (FLUTICASONE FUROATE)